bioRxivMicrobiology
The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice
L. Bao, W. Deng, B. Huang, H. Gao, J. Liu, L. Ren, Q. Wei, P. Yu, Y. Xu, F. Qi, Y. Qu, F. Li, Q. Lv, W. Wang, J. Xue, S. Gong, M. Liu, G. Wang, S. Wang, Z. Song, L. Zhao, P. Liu, L. Zhao, F. Ye, H. Wang, , C. Qin
Abstract
Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the Corona Virus Disease 2019 (COVID-19) cases in China has become a public health emergency of international concern (PHEIC). Based on angiotensin converting enzyme 2 (ACE2) as cell entry receptor of SARS-CoV, we used the hACE2 transgenic mice infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes and monocytes in alveolar interstitium, and accumulation of macrophages in alveolar cavities. Viral antigens were observed in the bronchial epithelial cells, alveolar macrophages and alveolar epithelia. The phenomenon was not found in wild type mice with SARS-CoV-2 infection. The pathogenicity of SARS-CoV-2 in hACE2 mice was clarified and the Kochs postulates were fulfilled as well, and the mouse model may facilitate the development of therapeutics and vaccines against SARS-CoV-2.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of low copy number human angiotensin-convertase 2 (hACE2)-transgenic mice as an improved model of SARS-CoV-2 infection
C. M. Bradshaw, T. Georgieva, … J. Z. Nikolich·bioRxiv·Aug 31, 2023
- K18-hACE2 mice develop respiratory disease resembling severe COVID-19
C. K. Yinda, J. R. Port, … V. Munster·bioRxiv·Aug 11, 2020
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
R. Rathnasinghe, S. Strohmeier, … M. B. Uccellini·Emerging Microbes & InfectionsPeer-reviewed·Jan 1, 2020
- Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection
G. B. Moreau, S. L. Burgess, … B. J. Mann·bioRxiv·Jun 26, 2020
- Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice
F. Oladunni, J.-G. Park, … J. B. Torrelles·bioRxiv·Jul 18, 2020
- Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W. Golden, Curtis R. Cline, … Jay W. Hooper·bioRxiv·Jul 9, 2020